98-9187. Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 67 (Wednesday, April 8, 1998)]
    [Notices]
    [Page 17186]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-9187]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Gastroenterology and Urology Devices Panel of the Medical Devices 
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Gastroenterology and Urology Devices Panel of 
    the Medical Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on April 30, 1998, 9:30 
    a.m. to 5 p.m.
        Location: Corporate Bldg., conference room 020B, 9200 Corporate 
    Blvd., Rockville, MD.
        Contact Person: Mary J. Cornelius, Center for Devices and 
    Radiological Health (HFZ-470), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-594-2194, ext. 118, or FDA 
    Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
    the Washington, DC area), code 12523. Please call the Information Line 
    for up-to-date information on this meeting.
        Agenda: The committee will discuss, make recommendations, and vote 
    on a premarket approval application for a lithotripter used to fragment 
    biliary stones.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by April 20, 
    1998. Oral presentations from the public will be scheduled between 9:30 
    a.m. and 10 a.m. Near the end of the committee deliberations, a 30-
    minute open public session will be conducted for interested persons to 
    address issues specific to the submission before the committee. Time 
    allotted for each presentation may be limited. Those desiring to make 
    formal oral presentations should notify the contact person before April 
    20, 1998, and submit a brief statement of the general nature of the 
    evidence or arguments they wish to present, the names and addresses of 
    proposed participants, and an indication of the approximate time 
    requested to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: April 1, 1998.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 98-9187 Filed 4-7-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
04/08/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-9187
Pages:
17186-17186 (1 pages)
PDF File:
98-9187.pdf